Atrium Advanta V12 Covered Stent System, 10mm x 59mm x 80cm (OUS)-Indicated for restoring and improving the patency of the iliac andrenal arteries. Renal approval includes 5mm, 6mm and 7mm diameter Advanta V12 covered stent sizes. In Canada, the Advanta V12 Covered Stent indication excludes renal arteries. REF: 85361
FDA Recall Z-0291-2024 · Posted 2023-11-11
Advertisement
Recalling FirmAtrium Medical Corporation
Recall StatusOpen, Classified
Product CodePRL
Date Initiated2023-09-21
Product Quantity141 units
Reason for Recall
Balloon-to-catheter weld failure that may cause loss of balloon pressure during stent deployment.
Firm Action
Atrium/Getinge issued URGENT Field Safety Notice -MEDICAL DEVICE REMOVAL on 9/25/23. Letter states reason for recall, health risk and action to take:
Please examine your inventory immediately to determine if you have any of the Advanta V12 covered stent
product listed above. Should you have any affected product, please remove from area(s) of use.
If you have affected product, you are entitled to a replacement at no cost to your facility or credit. You will
receive a replacement/credit upon your acknowledgement that you have affected product for return.
If you are a distributor who has shipped any affected products to customers, please forward this document to
their attention for appropriate action.
Once your customer response form has been received you will be contacted with shipping instructions to return
any affected product.
Whether or not you have affected product(s) with a LOT number listed in this notice, please complete and sign
the attached MEDICAL DEVICE- REMOVAL RESPONSE FORM (page 3) to acknowledge that you have received this
notification. Return the completed form to Atrium/Getinge to [email protected]
Type of Action by Getinge:
Atrium/Getinge has identified the cause of the issue and has implemented corrective measures to resolve the
noted manufacturing deficiency in the welding process, as well as additional detection measures implemented
to detect balloon weld defects. These corrective actions were implemented September 09, 2020. Product
Manufactured through the welding process after September 09, 2020 is not affected by this recall. If you have affected product, you will receive a replacement at no cost to your facility, or credit.
If you have any questions, please contact your Getinge representative or office.
Root Cause
Device Design
Distribution Pattern
Foreign: Australia, Belgium, Canada, France, Germany, Greece, Malta, Netherlands, New Zealand, Portugal, and United Kingdom
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement